SEARCH

SEARCH BY CITATION

References

  • Banada PP, Sivasubramani SK, Blakemore R et al. (2010) Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. Journal of Clinical Microbiology 48, 35513557.
  • Bistline K, Van Rie A, Page-Shipp L, Basset J & Sanne I (2011) Cost of Xpert MTB/RIF for smear-negative TB suspects at primary care clinic in Johannesburg. International Journal of Tuberculosis and Lung Disease 15, S61. Lille, France.
  • Boehme CC, Nabeta P, Hillemann D et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. New England Journal of Medicine 363, 10051015.
  • Boehme CC, Nicol MP, Nabeta P et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 6736, 111.
  • Cepheid (n.d.). GeneXpert System. from http://www.genexpert.com/pdfs/GeneXpert Brochure_0112-04.pdf (accepted 20 May 2011).
  • Chihota VN, Grant AD, Fielding K et al. (2010) Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. International Journal of Tuberculosis and Lung Disease 14, 10241031.
  • Dorman S, Manabe Y, Nicol M, Nakiyingi L, Moodley M & Zemanay W et al. (2012). Accuracy of Determine TB-LAM Lateral Flow Test for Diagnosis of TB in HIV+ Adults: interim results from a Multicenter Study. Conference on Retroviruses and Opportunistic Infections, Oral abstract, paper #149aLB. Seattle, USA.
  • Erasmus LK, Coetzee GJ & Stevens WS (2011) Scale up of Xpert MTB/RIF from the national laboratory perspective: issues and challenges. International Journal of Tuberculosis and Lung Disease 15, S61. Lille, France.
  • Health Systems Trust (2010). The District Health Barometer 2008/09. Health Systems Trust. http://www.hst.org.za/publications/district-health-barometer-200809 .
  • Helb D, Jones M, Story E et al. (2010) Rapid detection of Mycobacterium tuberculosis and Rifampin resistance by use of on-demand, near-patient technology. Journal of Clinical Microbiology 48, 229237.
  • Lawn SD, Kerkhoff AD & Wood R (2012) Location of Xpert® MTB/RIF in centralized laboratories in South Africa undermines potential impact. International Journal of Tuberculosis and Lung Disease 16, 701710.
  • Meyer-Rath G, Schnippel K, Long L et al. (2012) The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One 7(5), e36966. doi:10.1371/journal.pone.0036966.
  • Morris K (2010) Xpert TB diagnostic highlights gap in point-of-care pipeline. The Lancet Infectious Diseases 10, 742743. Elsevier Ltd.
  • National Department of Health (2009). South African National Tuberculosis Guidelines. National Department of Health, Pretoria.
  • Nicol MP, Workman L, Isaacs W et al. (2011) Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. The Lancet Infectious Diseases 11, 819824. Elsevier Ltd
  • Oanda.com (2011). Oanda average exchange rates. from http://www.oanda.com/currency/average (accepted 28 September 2011).
  • Page-Shipp L, Dansey H, Basset J et al. (2011) Point of care Xpert MTB/RIF for smear-negative TB diagnosis at a primary care clinic in South Africa. International Journal of Tuberculosis and Lung Disease 15, S61. Lille, France.
  • Scott LE, Mccarthy K, Gous N et al. (2011) Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Medicine 8, 111.
  • Small PM & Pai M (2010) Tuberculosis diagnosis — time for a game change. New England Journal of Medicine 363, 10701071.
  • Smart T (2011). GeneXpert to be rolled out as first-line diagnostic for TB in South Africa. HIV & AIDS treatment in practice. from http://www.aidsmap.com/GeneXpert-to-be-rolled-out-as-first-line-diagnostic-for-TB-in-South-Africa/page/1746803/ (accepted 10 November 2011).
  • South African Reserve Bank (2011). Selected historical exchange rates and other interest rates. from http://www.resbank.co.za/Research/Rates/Pages/SelectedHistoricalExchangeAndInterestRates.aspx (accepted 14 November 2011).
  • Sreeramareddy CT, Panduru KV, Menten J & Van den Ende J (2009) Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infectious Diseases 9, 91 doi:10.1186/1471-2334-9-91.
  • Stop TB Department (2006). Planning and budgeting for TB control model. World Health Organization. from http://www.who.int/tb/dots/planning_budgeting_tool/en/ (accepted 28 July 2011).
  • Stop TB Department (2010). Roadmap for Rolling Out Xpert MTB/RIF for Rapid Diagnosis of TB and MDR-TB (pp. 112). World Health Organization, Geneva.
  • Theron G, Pooran A, Peter J et al. (2011) Adjunct TB tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? ERJ. doi: 10.1183/09031936.00145511.
  • Trébucq A, Enarson DA, Chiang CY et al. (2011) Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how? International Journal of Tuberculosis and Lung Disease 15, 15671571.
  • Vadwai V, Boehme CC, Nabeta P, Shetty A, Alland D & Rodrigues C (2011) Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? Journal of Clinical Microbiology, 49 25402545.
  • Van Rie A, Page-Shipp L, Scott L, Sanne I & Stevens W (2010) Xpert ® MTB/RIF for point-of- care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Review of Molecular Diagnosis 10, 937946.
  • Vassall A, van Kampen S, Sohn H et al. (2011) Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Medicine 8, e1001120.
  • World Health Organization (2011a) Global Tuberculosis Control. World Health Organization, Geneva.
  • World Health Organization (2011b) Rapid Implementation of the Xpert MTB/RIF Diagnostic test: Technical and Operational “How-to”; Practical Considerations. World Health (WHO/HTM/TB.). World Health Organization, Geneva.